Business · 1 sources covering this

FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

CNBCLean R·1h ago
FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.
Read at CNBC →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/677d05493005afc71f916a0639456c4a501636ef"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound"></iframe>

FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

How 1 sources are covering this

FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

More from Business

S&P 500 futures rise as traders brace for crucial consumer inflation report: Live updates

Trump says FBI investigating Nvidia boss's affair with alleged Chinese spy

SoftBank swings to $7 billion net loss in second quarter as tech selloff weighs on results

Faisal Islam: What Jensen Huang told me about China, national security and persuading Trump

Reader

Trust & legal

Across the network